Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 21.
doi: 10.1515/znc-2024-0208. Online ahead of print.

Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook

Affiliations
Review

Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook

Saraswati Patel et al. Z Naturforsch C J Biosci. .

Abstract

An ideal drug carrier system should demonstrate optimal payload and release characteristics, thereby ensuring prolonged therapeutic index while minimizing adverse effects. The field of drug delivery has undergone significant advancements, particularly within the last two decades, owing to the revolutionary impact of biomaterials. The use of biomaterials presents significant due to their biocompatibility and biodegradability, which must be addressed in order to achieve effective drug delivery. The properties of the biomaterial and its interface are primarily influenced by their physicochemical attributes, physiological barriers, cellular trafficking, and immunomodulatory effects. By attuning these barriers, regulating the physicochemical properties, and masking the immune system's response, the bio interface can be effectively modulated, leading to the development of innovative supramolecular structures with enhanced effectiveness. With a comprehensive understanding of these technologies, there is a growing demand for repurposing existing drugs for new therapeutic indications within this space. This review aims to provide a substantial body of evidence showcasing the productiveness of biomaterials and their interface in drug delivery, as well as methods for mitigating and modulating barriers and physicochemical properties along with an examination of future prospects in this field.

Keywords: bio interface; biomaterial; cellular uptake; drug delivery; physicochemical.

PubMed Disclaimer

Similar articles

References

    1. Mainardes, RM, Silva, LP. Drug delivery systems: past, present, and future. Curr Drug Targets 2004;5:449–55. https://doi.org/10.2174/1389450043345407 . - DOI - PubMed
    1. Buckles, RG. Biomaterials for drug delivery systems. J Biomed Mater Res 1983;17:109–28. https://doi.org/10.1002/jbm.820170110 . - DOI - PubMed
    1. Adepu, S, Ramakrishna, S. Controlled drug delivery systems: current status and future directions. Molecules 2021;26:5905. https://doi.org/10.3390/molecules26195905 . - DOI - PubMed - PMC
    1. Peppas, NA, Langer, R. New challenges in biomaterials. Science 1994;263:1715–20. https://doi.org/10.1126/science.8134835 . - DOI - PubMed
    1. Sant, S, Tao, SL, Fisher, O, Xu, Q, Peppas, NA, Khademhosseini, A. Microfabrication technologies for oral drug delivery. Adv Drug Deliv Rev 2012;64:496–507. https://doi.org/10.1016/j.addr.2011.11.013 . - DOI - PubMed - PMC

LinkOut - more resources